San Diego-centered Viking Therapeutics marked alone as a significant competitor while in the weight loss drug current market in February right after revealing promising information from a mid-phase demo of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when offered for a weekly injection and in Marc